| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Sangamo Therapeutics, Inc (SGMO) has 6 insiders with recent SEC Form 4 filings, including 0 buys and 11 sells. SGMO is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.90M | $331.6K | - | |
| Other | 696.7K | $121.9K | - | |
| VP | 647.4K | $113.3K | - | |
| VP | 328.7K | $57.5K | - | |
| Other | 235.3K | $41.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 2, 2018 | Mento Steven J | Director | Sale+OE | 7,215 | $18.40 | $132,758.33 | -23.3% | |
| Mar 15, 2018 | Yi Kathy | SVP &Chief Financial Officer | Sale+OE | 5,000 | $25.56 | $127,812.00 | -40.8% | |
| Mar 6, 2018 | Conner Edward R. | Sr. VP &Chief Medical Officer | Sale+OE | 5,000 | $24.78 | $123,877.50 | -38.1% | |
| Mar 1, 2018 | Herberts Curt A. III | Sr.vp &Chief Business Officer | Sale+OE | 15,000 | $23.06 | $345,861.00 | -50.6% | |
| Mar 1, 2018 | Mento Steven J | Director | Sale+OE | 9,433 | $23.27 | $219,546.47 | -51.0% | |
| Feb 26, 2018 | Ramasastry Saira54 | Director | Sale+OE | 9,450 | $24.88 | $235,080.09 | -100% | |
| Feb 6, 2018 | Conner Edward R. | Sr. VP &Chief Medical Officer | Sale+OE | 5,000 | $18.49 | $92,435.50 | -38.1% | |
| Feb 1, 2018 | Mento Steven J | Director | Sale+OE | 11,520 | $20.59 | $237,158.78 | -76.8% | |
| Feb 1, 2018 | Herberts Curt A. III | Sr.vp &Chief Business Officer | Sale+OE | 15,000 | $20.59 | $308,854.50 | -50.6% | |
| Jan 8, 2018 | Conner Edward R. | Sr. VP &Chief Medical Officer | Sale+OE | 5,000 | $17.11 | $85,545.00 | -71.4% |